MARCHF1 and hepatocellular carcinoma: To further determine whether MARCH1 had any effects on the HCC cells’ proliferation, we treated the HepG2 and Hep3B cells with targeted MARCH1 siRNAs and then conducted a CCK‐8 analysis of the cell viability.